Antimalarial combination therapies increase gastric ulcers through an imbalance of basic antioxidative-oxidative enzymes in male Wistar rats
Open Access
- 23 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Research Notes
- Vol. 13 (1), 1-6
- https://doi.org/10.1186/s13104-020-05073-7
Abstract
Objective Antimalarials are globally used against plasmodium infections, however, information on the safety of new antimalarial combination therapies on the gastric mucosa is scarce. The aim of this study was to investigate the effects of Artesunate-Amodiaquine and Artemether-Lumefantrine on ulcer induction. Malondialdehyde (MDA), reduced glutathione (GSH) and major histological changes in male Wistar rats following ulcer induction using Indomethacin were investigated. Gastric ulcers were in four groups; Group I was administered Artesunate, group II received Artesunate-Amodiaquine, group III received Artemether-Lumefantrine, and group IV was a positive control (normal saline). Group V was the negative control consisting of healthy rats. Results Antimalarial combination therapies were associated with a high gastric ulcer index than a single antimalarial agent, Artesunate. In addition, levels of MDA were significantly higher in the combination of therapies while levels of GSH were lower in comparison to Artesunate and the negative control. Microscopically, antimalarial combination therapies were associated with severe inflammation and tissue damage than Artesunate in the gastric mucosa showing that antimalarial combination therapies exert their toxic effects through oxidative stress mechanisms, and this leads to cellular damage. Findings in this study demonstrate a need to revisit information on the pharmacodynamics of major circulating antimalarial agents in developing countries.Keywords
This publication has 41 references indexed in Scilit:
- Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, LiberiaMalaria Journal, 2013
- Artemether–lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from TanzaniaMalaria Journal, 2012
- Comparison of Indomethacin, Diclofenac and Aspirin-Induced Gastric Damage according to Age in RatsGut and Liver, 2012
- Artesunate-amodiaquine fixed dose combination for the treatment of Plasmodium falciparum malaria in IndiaMalaria Journal, 2012
- Costs analysis of the treatment of imported malariaMalaria Journal, 2012
- Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the ProgressPharmaceuticals, 2010
- Artemisinin-based combination therapies: a vital tool in efforts to eliminate malariaNature Reviews Microbiology, 2009
- Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized TrialPLoS Clinical Trials, 2007
- Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria in UgandaPLoS Clinical Trials, 2006
- Gastroprotective and Anti-secretory Effect of Nigella sativa Seed and its Extracts in Indomethacin-treated RatsPakistan Journal of Biological Sciences, 2004